objects |
administration route |
mechanisms of neurotoxicity |
references |
|
rats |
intravenous injection |
indirect mechanism (induced by cytokines and pro-inflammatory mediators in systemic circulation) |
[6] |
mice |
nasal administration |
inflammatory response (over-proliferation in glia cells) |
[29] |
rats |
intravenous injection |
OS and angiotensin system |
[22] |
rats |
intravenous injection |
multiple (OS, inflammatory response and DNA damage) |
[55] |
mice |
oral administration |
OS (ROS and anti-oxidant enzymes disturbed) |
[23] |
mice |
inhalation |
OS (H2O2 and MDA elevated) |
[24] |
mice |
oral administration |
other mechanisms |
[57] |
mice |
intranasal administration |
inflammatory response |
[30] |
pregnant rats |
subcutaneous injection |
OS |
[26] |
pregnant rats |
oral administration |
other mechanisms (cell proliferation inhibited) |
[58] |
pregnant mice |
subcutaneous injection |
other mechanisms (disrupted dopamine systems) |
[59–60] |
pregnant mice |
subcutaneous injection |
multiple mechanisms (apoptosis, OS and neurotransmitters) |
[50] |
mice |
nasal instillation |
OS |
[21] |
mice |
nasal instillation |
multiple mechanisms (OS and inflammatory response) |
[49] |
mice |
delivery in abdominal cavity |
OS |
[25] |
mice |
intragastric administration |
other mechanisms (disturbed distributions of trace elements, enzymes and neurotransmitters) |
[61] |
mice |
intragastric administration |
multiple mechanisms (apoptosis and OS) |
[54] |
mice |
intranasal administration |
P38-Nrf-2-mediated OS |
[31] |
neonatal rats |
lactation exposure orally |
disturbed synaptic plasticity |
[62] |
rats |
trachea administration |
inflammatory response |
[32] |
mice |
injection in abdominal cavity |
genotoxicity induced by OS |
[43] |